According to Transgene SA's latest financial reports the company's current EPS (TTM) is -HK$18.68. In 2022 the company made an earnings per share (EPS) of -HK$2.75 a decrease over its 2021 EPS that were of -HK$1.85.
Year | EPS | Change |
---|---|---|
2022 | -HK$2.75 | 48.16% |
2021 | -HK$1.85 | -6.93% |
2020 | -HK$1.99 | -0.6% |
2019 | -HK$2.00 | -273.41% |
2018 | HK$1.16 | -124.48% |
2017 | -HK$4.72 | 31.82% |
2016 | -HK$3.58 | -63.87% |
2015 | -HK$9.91 | -14.59% |
2014 | -HK$11.60 | -17.15% |
2013 | -HK$14.00 | 2.99% |
2012 | -HK$13.60 | 0.3% |
2011 | -HK$13.56 | 8.93% |
2010 | -HK$12.45 | -7.32% |
2009 | -HK$13.43 | 56.96% |
2008 | -HK$8.56 | 176.84% |
2007 | -HK$3.09 | -77.81% |
2006 | -HK$13.93 | -25.75% |
2005 (TTM) | -HK$18.76 | -18.76% |
2004 | -HK$23.09 | 18.71% |
2003 | -HK$19.45 | 35.08% |
2002 | -HK$14.40 | -16.55% |
2001 | -HK$17.26 | -37.1% |
2000 | -HK$27.44 | 13.45% |
1999 | -HK$24.18 | -60.26% |
1998 | -HK$60.86 | 109.21% |
1997 | -HK$29.09 |